Severe acute respiratory syndrome (SARS): a year in review
- PMID: 15660517
- DOI: 10.1146/annurev.med.56.091103.134135
Severe acute respiratory syndrome (SARS): a year in review
Abstract
Severe acute respiratory syndrome (SARS) emerged from China as an untreatable and rapidly spreading respiratory illness of unknown etiology. Following point source exposure in February 2003, more than a dozen guests infected at a Hong Kong hotel seeded multi-country outbreaks that persisted through the spring of 2003. The World Health Organization responded by invoking traditional public health measures and advanced technologies to control the illness and contain the cause. A novel coronavirus was implicated and its entire genome was sequenced by mid-April 2003. The urgency of responding to this threat focused scientific endeavor and stimulated global collaboration. Through real-time application of accumulating knowledge, the world proved capable of arresting the first pandemic threat of the twenty-first century, despite early respiratory-borne spread and global susceptibility. This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise.
Similar articles
-
[Severe acute respiratory syndrome: the first transmissible disease of the 21st century].Recenti Prog Med. 2003 Jul-Aug;94(7-8):295-303. Recenti Prog Med. 2003. PMID: 12868234 Review. Italian.
-
Severe acute respiratory syndrome-associated coronavirus infection.Emerg Infect Dis. 2003 Nov;9(11):1453-4. doi: 10.3201/eid0911.030421. Emerg Infect Dis. 2003. PMID: 14718090 Free PMC article.
-
Severe acute respiratory syndrome: lessons and uncertainties.Neth J Med. 2003 Jul;61(7):235-7. Neth J Med. 2003. PMID: 14567519 Review.
-
[Severe acute respiratory syndrome (SARS). The questions raised by the management of a patient in Besançon and Strasbourg].Presse Med. 2003 Sep 13;32(29):1359-64. Presse Med. 2003. PMID: 14534497 French.
-
Confronting SARS: a view from Hong Kong.Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1075-9. doi: 10.1098/rstb.2004.1482. Philos Trans R Soc Lond B Biol Sci. 2004. PMID: 15306392 Free PMC article.
Cited by
-
Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1.PLoS One. 2024 Jan 26;19(1):e0297262. doi: 10.1371/journal.pone.0297262. eCollection 2024. PLoS One. 2024. PMID: 38277395 Free PMC article.
-
Detection of Antibodies against Endemic and SARS-CoV-2 Coronaviruses with Short Peptide Epitopes.Vaccines (Basel). 2023 Aug 23;11(9):1403. doi: 10.3390/vaccines11091403. Vaccines (Basel). 2023. PMID: 37766081 Free PMC article.
-
The role of vaccines in the COVID-19 pandemic: what have we learned?Semin Immunopathol. 2024 Jan;45(4-6):451-468. doi: 10.1007/s00281-023-00996-2. Epub 2023 Jul 12. Semin Immunopathol. 2024. PMID: 37436465 Free PMC article. Review.
-
Antiviral PROTACs: Opportunity borne with challenge.Cell Insight. 2023 Mar 27;2(3):100092. doi: 10.1016/j.cellin.2023.100092. eCollection 2023 Jun. Cell Insight. 2023. PMID: 37398636 Free PMC article. Review.
-
Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development.Viruses. 2023 Mar 31;15(4):914. doi: 10.3390/v15040914. Viruses. 2023. PMID: 37112894 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous